CHICAGO -- A randomized trial testing the addition of selinexor (Xpovio) to ruxolitinib (Jakafi) for myelofibrosis only met one of its two primary endpoints, yet the combination also showed a ...
Just as the Reds' bullpen has appeared to have regained some of its footing this week, it was dealt another injury blow that ...
Agios obtains exclusive global rights to novel, late-stage, next-generation, oral SYK inhibitorAgreement diversifies Agios’ rare hematology portfolio with expansion into immune thrombocytopenia, ...
("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires ...
Aspire Biopharma Holdings. We are moving with speed to transform our clinical pipeline into commercial reality, broadening the market reach of our high growth consumer segment, while simultaneously ...
Hosted on MSN
The world's most painful medical procedures ranked by a doctor: From spinal taps to knee replacement
While medical procedures are entirely necessary and life-saving, it doesn’t mean they’re painless. In fact even those carried out under general anaesthetic, which is supposed to prevent you from ...
Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Serous Carcinoma June 2, 2026 8:00 ...
Doctors explain the most common causes of hair loss, from stress and thyroid issues to medications, menopause, and nutrient ...
Unmanaged heel pain can be incredibly difficult to live with, but the best shoes for plantar fasciitis help alleviate ...
In 2025, Lacavera teamed up with fitness guru and self-proclaimed “life engineer” Gary LeBlanc to launch EverMe, a mobile app ...
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results